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Abstract
A prebiotic is a selectively fermented ingredient that results in specific changes in the
composition and/or activity of the gastrointestinal microbiota, thus conferring benefit(s)
upon host health. The most widely accepted prebiotics are lactulose, inulin, fructooligo‐
saccharides (FOS), galactooligosaccharides (GOS), and the human milk oligosacchar‐
ides (HMO). However, there is a growing list of potential prebiotics although the evidence
for these, especially in humans, is not as well established as for FOS and GOS. Some of
them  are  already  commercialized  but  others  such  as  polydextrose  (PDX),  pectic
oligosaccharides (POS), bacterial exopolysaccharides (EPS), polysaccharides derived
from algae and sugar alcohols are still in the early stages of development. This chapter
summarizes the scientific literature regarding the manufacture and the evaluation of the
properties of this group “emerging prebiotics”.
Keywords: emerging prebiotics, pectic oligosaccharides, polydextrose, algae-derived
oligosaccharides, bacterial exopolysaccharides, sugar alcohols
1. Introduction
The consumption of prebiotics is being specially considered as a good health-improving strategy;
they have been recently defined as “nondigestible compounds that through its metaboliza‐
tion by microorganisms in the gut, modulate the composition and/or the activity of the gut
microbiota, thus conferring physiological benefit effects on the host health” [1].
The microbial communities that inhabit the human intestinal tract constitute a complex
association, comprising more than 1000 species and around 1014 microorganisms, mainly
anaerobic (>99.9%). Figure 1 shows the human gastrointestinal tract, indicating the different
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levels of microorganisms and the main bacterial groups. Along the jejunum, and particular‐
ly in the ileum, there is a gradual increase in the number and diversity of bacteria, and finally,
the majority of gastrointestinal microbes are housed in the colon [2].
Figure 1. The human gastrointestinal tract (CFU, colony-forming units).
However, scientific works on this field suggest that the gut microbiota is not only a simply
collection of microorganisms, but also reflects an interrelationship between the different
groups that might work together for the benefit of the host [2]. In addition, the microbiota also
establishes a close symbiosis with the host: humans provide the nutrients and the appropri‐
ate conditions for its development, and it performs three essential primary functions: meta‐
bolic, trophic, and defensive [3]. In fact, there is a long list of pathologies which are linked to
the alteration of the gut microbiota, including hepatic encephalopathy, diarrhea, diabetes,
obesity, colon cancer, IBS, IBD, gastrointestinal infections, and necrotizing enterocolitis [4, 5].
The composition of the gut microbiota is influenced by a variety of factors that include: (i) the
microbial species which are acquired at birth, (ii) host genetics, (iii) age [6–8], (iv) diseases and
antibiotic usage [9, 10], (v) the stress [11], and (vi) the diet. In fact, the diet is probably the most
important factor and several studies are focused on the modulation of the gut microbiota by
the consumption of functional foods, such as prebiotics [12–14].
For considering a food ingredient as a prebiotic, it must fulfill the following requirements [15]:
(i) it cannot be hydrolyzed or absorbed in the upper gastrointestinal tract, (ii) it has to
encourage the development of beneficial bacteria such as bifidobacteria and lactobacilli, and
(iii) it must induce beneficial physiological effects on the host health, so that well-conducted
human trials are required.
In addition to the generally identified as beneficial bacteria (bifidobacteria, lactobacilli, and
even, eubacteria), a recent review by Hill et al. [16] indicates that the species Akkermansia
muciniphila and Faecalibacterium prausnitzii, and others such as Roseburia spp. and Eubacteri‐
um hallii, which could be useful to alleviate gut inflammation, to induce and regulate of the
immune system or to improve the intestinal barrier function.
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The most widely accepted prebiotics are lactulose, inulin, fructooligosaccharides (FOS),
galactooligosaccharides (GOS), and the human milk oligosaccharides (HMO). However, there
is a growing list of potential prebiotics and some of them are already commercialized and
others, like polydextrose (PDX), pectic oligosaccharides (POS), bacterial exopolysaccharides
(EPS), polysaccharides derived from algae and sugar alcohols that are still in the early stages
of study [15]. This chapter summarizes the scientific literature regarding the manufacture and
evaluation of this group of emerging prebiotics.
2. Pectic oligosaccharides (POS)
POS have been recently classified as emerging prebiotics and their potential is currently being
evaluated.
2.1. Raw materials for POS production
POS are oligosaccharides that can be obtained by partial hydrolysis of pectins, which are
heteropolysaccharides with a highly complex structure.
Pectins are mainly made up by a backbone of galacturonic acid units (GalA) connected by α-
(1,4) links that can be randomly acetylated at the O-2 and/or O-3 positions and methylated at
C-6. This fraction is known as “smooth region,” and it is occasionally interrupted by the
“hairy region,” where side chains, formed by a variety of neutral sugars, can be found. Figure 2
shows the major structural fragments of pectin:
Figure 2. Simplified structure of pectin.
a. Homogalacturonan (HG). HG is a linear polymer consisting of a chain with an estimat‐
ed length of 72–100 GalA units that represent, approximately, 60% of the total pectin [17].
Acetylation and methylation degrees (DA and DM, respectively) vary according to the
origin and the development stage of the plant [18].
b. Xylogalacturonan (XG). XG is a chain of GalA residues partially substituted by D-xylose
residues connected by β-(1,3) links at C-3 and/or C-2 positions.
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c. Rhamnogalacturonan I (RG-I). It represents up to 7–14% of the pectins [19] and contains
alternating units of α-(1,4)-galacturonosyl and α-(1,2)-rhamnosyl. In many cases,
rhamnose residues show side chains as substituents on the O-4 position, made up of
arabinan and/ or arabinogalactan I and II, although lower concentrations of xylose or
glucose can be also found [18].
d. Rhamnogalacturonan II (RG-II). RGII is a region characterized by a length of 7–9 GalA
units, where complex branches made up of 12 types of monosaccharides (as a maxi‐
mum) can exist, including some minority monomers such as apiose, fucose, acetic acid,
DHA, or KDO [20].
Pectin has a great number of applications including its use as ingredient for medicaments for
treating gastrointestinal disorders, diabetes, high blood pressure, or hypercholesterolemia [21–
23].
Currently, citrus pulp and apple pomace are the major sources of pectin, but this polymer can
also be found in other agro-products such as sugar beet pulp [24].
2.2. Manufacture and purification
Several methods have been used for POS production from both agro-industrial byproducts
and purified pectins, including partial enzymatic hydrolysis, acid hydrolysis, hydrothermal
treatments, dynamic high-pressure microfluidization, or photochemical reaction in media
containing TiO2 [24].
Chemical methods include the acidic or basic hydrolysis of α and β-glucosidic links of the
principal chains of HG, RG-I, and RG-II and their side chains. These methodologies include
hydrothermal treatments and processes where external acids are added. In both cases,
hydronium ions act as catalytic species [24]. A variety of raw materials such as orange albedo,
apple pulp, or deesterified beet pulp have been treated to obtain POS, using acids such as
HNO3, HCl, or TFA [24], although alkalis (KOH) can also be employed [25]. POS mixtures have
been obtained from lemon and orange peel wastes [26–28], dried apple pomace [29], sugar beet
pulp [30], or alperujo [31] using stainless steel reactors, whereas Sato et al. [32] employed both
a batch and a continuous tubular flow reactor to produce arabinooligosaccharides (AraOS)
and feruloylated AraOS from beet fiber.
As an alternative, pectin-degrading enzymes constitute a group of enzymes that catalyze the
degradation of the pectic polymers in plant cells. Although pectins have a complex structure,
they can be modified by diverse enzymes, including hydrolases, lyases, and esterases [33].
Several raw materials with different characteristics have been enzymatically treated, such as
bergamot peel [34], gum tragacanth [35, 36], ginseng pectin [37], orange peel wastes [38], lemon
peel wastes [39], sugar beet [40, 41], apple pectin [42], or medicinal herbs [43].
Both mono-active and commercial mixtures can be used for pectin depolymerization; however,
mono-active enzymes target only specific structures, causing the release of more defined
oligosaccharides than when commercial enzyme mixtures or chemical treatments are em‐
ployed [44]. Mixture of several preparations have been widely employed for POS produc‐
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tion [38, 41, 45–48]. A comparable yield respect to acidic treatments can be achieved using
enzyme preparations [42].
In addition, enzymes can be also advantageous for the alteration of the methylation or
acetylation degree of the polymer [44].
On the other hand, chemical and enzymatic hydrolysis have been combined to depolymer‐
ize pectin [49] or to obtain different pectin fractions, such as POS and neutral and acidic
xylooligosaccharides [31]. Other technologies that have been combined are enzymatic and
microwave-assisted alkaline extraction [48], hydrothermal and acid treatment for polygalac‐
turonic acid hydrolysis [50], subcritical water and ultrasonic-assisted treatments [51].
Finally, physical technologies (for instance, the dynamic high-pressure microfluidization
under acidic conditions) have been emerged as innovative [52].
After production, purification stages are usually needed to obtain a product suitable to be used
as food ingredient. The most common purification technique is the membrane filtration. A
process involving diafiltration followed by concentration was performed by Gómez et al. [26]
to purify pectic oligosaccharides from autohydrolysis liquors obtained from lemon peel
wastes, yielding a refined product with about 98 wt% of oligomers which contained oligoga‐
lacturonides (with DP in the range of 2–18) and AraOS (with DP in the range of 2–8). A similar
approach was performed by Gómez et al. [27] achieving a refined final product containing 90%
of the target product, where there were identified AraOS (DP 3–21), GalOS (DP 5–12), and
OGalA (DP 2–12), with variable DM and also long-chain products.
Rubio-Senent et al. [53] isolated fractions (MW > 3 kDa) which were rich in pectic material from
an alperujo aqueous hydrolysate by ultrafiltration thought 3 kDa regenerated cellulose.
Ultrafiltration and diafiltration (50 kDa cut-off) were employed by Sulek et al. [54] to isolate
AraOS, which were further fractionated into a stirred membrane reactor equipped with a 1
kDa MWCO.
This methodology has also been employed to sequentially fractionate oligosaccharides by its
molecular weight [55].
Other alternatives were also used in this field; Lama-Muñoz et al. [31] fractionated and purified
neutral and POS by adsorption XAD chromatography (Amberlite XAD-16 resin), and the gel
Sephadex G-75 was selected by Lee et al. [56] to purify POS from Korean Citrus Hallabong
peels.
2.3. Prebiotic potential of POS
POS have been suggested as a new class of prebiotics, which are capable of exerting a number
of health-promoting effects, including [24] stimulation of apoptosis in human colonic
adenocarcinoma cells, potential for cardiovascular protection in vivo, reduction of damage by
heavy metals, antiobesity effects, antitoxic, antiinfection, antibacterial, and antioxidant
properties.
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The main derived products from the intestinal bacterial fermentation of POS, as well as from
other dietary fiber, are the SCFA (acetate, propionate, and butyrate). SCFA exert several
beneficial effects including: (i) a key role in the prevention and treatment of the metabolic
syndrome, bowel disorders, and cancer [57–59]; (ii) protection against diet-induced obesity
and regulation of the gut hormones [60]; or (iii) a positive effect on the treatment of ulcera‐
tive colitis, Crohn’s disease, and antibiotic-associated diarrhea and obesity [61–63]. Particu‐
larly, butyrate is the major energy source for the colonocytes, propionate has a role in
gluconeogenesis processes, and acetate is used for the lipogenesis [64].
The following paragraphs summarize the results derived from the recent in vitro and in vivo
studies carried out employing POS as substrate:
a) In vitro assays
Citrus peel wastes and sugar beet pulp were subjected to hydrothermal treatment and the
resulting liquors refined by membrane filtration. The final POS mixtures were then ferment‐
ed by human fecal samples leading to an increase of the bacterial population of up to eight
different groups. Specifically, POS from sugar beet pulp showed the highest bifidogenic
potential and the maximum SCFA concentration. Meanwhile, the largest increase in
Lactobacillus population was observed using POS from orange peel wastes as a carbon source,
whereas the best results for other bacterial groups such as Eubacterium, Faecalibacterium, or
Roseburia were observed for POS from lemon peels wastes [27, 65]. In the same way, POS
derived from sugar beet (enriched in AraOS) were used as substrates in in vitro fermentation
assays of POS leading to increases in bifidobacteria populations (which preferred low
molecular weight fractions) without stimulating the growth of Clostridium [66–68]. In a recent
study with POS from sugar beet pulp containing GalOS, AraOS, and mixtures of acidic
oligosaccharides (mainly made up of RG and HG oligosaccharides), no a clear bifidogenic
effect was observed, whereas important increases of Faecalibacterium were reported. Moreover,
the SCFA concentrations were found higher in experiments with POS than with FOS [69].
Regarding apple pectin, a variety of works were reported concluding that POS might be an
interesting prebiotic candidate with slightly improved physiological properties if they are
compared to commercial ones. In this context, Gulfi et al. [70] indicated that pectin hairy
regions from ripe apples revealed to be a very readily fermentable substrate for human colonic
bacteria, showing a substantial impact on pH and SCFA production. Suzuki et al. [71] found
that AraOS from apple pectin, especially those that consist of more than three units, are more
selectively utilized by Bifidobacterium adolescentis, B. longum, and Bacteroides vulgatus than FOS
and XOS. Meanwhile, Chen et al. [52] reported the ability of apple-derived POS for promot‐
ing the bifidobacteria and lactobacilli growth and for decreasing numbers of bacteroides and
clostridia, whereas the fermentation of refined POS mixture from apple pomace with human
feces resulted in an increase in the populations of Bifidobacterium, Eubacterium rectale and
Lactobacillus, but also of Clostridium and Bacteroides [72].
Some authors as Mandalari et al. [12] employed other types of pectin sources, demonstrating
that almond seeds, which contain arabinose-rich pectin, exhibited potential for their use as a
novel sources of prebiotics, increasing the populations of bifidobacteria and Eubacterium rectale
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with the subsequent increase in butyrate concentrations. Guevara-Arauza et al. [73] ob‐
served that POS from nopal act as prebiotics, reducing putrefactive ammonium production,
increasing SCFA production, and sustaining bifidogenic effects over longer periods of time.
In addition, in order to elucidate structure–function relationships in POS, Onumpai et al. [74]
compared the fermentation properties of pectin fractions and their parent pectins using a pH-
controlled fecal fermentation system. All of the tested carbohydrates increased the popula‐
tions of bacteroides, but just galactan- and arabinan-derived oligosaccharides increased the
bifidobacteria counts. On the other hand, methylated oligogalacturonides, compared to the
parent polysaccharide and to other pectic fractions, caused a significant increase in the
Faecalibacterium prausnitzii populations [74].
b) In vivo assays
Despite the advances in in vitro models, the in vivo studies involving the use of animals and
especially of humans provide the best models for studying the changes in the microbiota
populations. However, they often require specialist facilities and are both expensive and time-
consuming, limiting the number of this type of assays [75].
Jiao et al. [76] demonstrated that water-soluble oligosaccharides isolated from Panax gin‐
seng significantly inhibited tumor growth in mice by enhancing their immune system. In this
last year, native intact (TrPP) and modified, low molecular weight (MTrPP) forms of pectic
polysaccharides isolated from turmeric were evaluated for ulcer-preventive potentials in in
vivo rat models. MTrPP was rich in galacturonic acid (687 mg/g; TrPP-544 mg/g) and galac‐
tose (52.9%; TrPP-21.7%) from HG and RG-I containing galactan. The results suggested that
MTrPP possess significantly improved ulcer-preventive properties than TrPP (inhibiting ulcer
scores up to 85%), revealing that the fine structural features of pectin are crucial in deliver‐
ing its therapeutic benefits against gastric ulcer [77].
Regarding the clinical assays, Fanaro et al. [78] observed increased counts of bifidobacteria
and lactobacilli by the administration of POS as a component of infant formulae. Similarly,
Magne et al. [79] detected increased proportions of bifidobacteria in the mixture GOS/FOS/POS
respect to the mixture GOS/FOS, as well as the proportions of Bacteroides and Clostridium
coccoides decreased. Moreover, the use of neutral and acidic oligosaccharides to preterm
infants (mixtures of POS, GOS and FOS) showed a trend toward a lower incidence of serious
endogenous infection and serious infectious episodes [80]. Finally, the intake of POS in a
mixture with short-chain GOS and long-chain FOS by volunteers who were in the earlier stages
of HIV-1 infection, resulted in the modulation of gut microbiota by increasing the bifidobac‐
teria numbers and by decreasing the counts of pathogens [81].
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3. Polydextrose (PDX)
3.1. Structure and manufacture
PDX is an artificial highly branched polysaccharide synthesized conventionally by random
polycondensation of glucose with sorbitol and a food grade acid (e.g., citric acid) as catalyst,
at a high temperature and under partial vacuum [82]. Recently, other methods have been
explored as the synthesis by microwave irradiation [83]. PDX is composed of a mixture of
glucose oligomers, with an average degree of polymerization (DP) of 12, ranging from DP 2–
120 [84, 85] and contains all different combinations of α- and β-(1,2), (1,3), (1,4), and (1,6)
glycosidic linkages, but α-( 1,6) linkages are predominant [85, 86]. PDX is regarded as a
resistant polysaccharide [87] and it is widely used in the food industry as a low-energy bulking
agent (1 kcal/g) and as a sugar or fat replacer [86].
3.2. Prebiotic effects
Due to its complex structure and to the nature of its glycosidic bonds, PDX is resistant to
mammalian digestive enzymes in the upper gastrointestinal tract. For this reason, PDX reaches
the colon intact where it is partially fermented by gut microbiota, stimulating selectively target
bacterial groups [84, 85, 88]. These two characteristics, indigestibility and selective fermenta‐
bility, support that the PDX has been identified as a source of prebiotic fiber with several health-
promoting effects [89], including:
• Improvement of the bowel function, by promoting the growth of beneficial bacteria (e.g.,
bifidobacteria and lactobacilli) while preventing the growth of harmful ones (such as
clostridia and bacteroides), decrease of fecal pH and increase of the residual concentration
of short chain fatty acids (SCFA) [88].
• Reduction of the risk of colon cancer development [88, 90].
• Modulation of the lipid metabolism, decreasing the total cholesterol and LDL cholesterol
and increasing HDL cholesterol [84].
• Prevention of the adhesion of opportunistic pathogens related with meningitis and sepsis
in neonates [91].
• Anti-inflammatory action [92] and positive effects on canine osteoarthritis [93].
• Reduction of the symptoms of human atopic eczema [94].
• Improvement of the absorption of magnesium, calcium and iron [95–97]. The studies related
to the biological and prebiotics effects of PDX (observed in vivo, in vitro and human
intervention assays) are summarized in Table 1.
Biological and prebiotic effects Study typeReferences
Proliferation of Lactobacillus and Bifidobacterium species and decreases in Bacteroides species. Increases in concentrations of SCFA. Improvement
of the bowel function and inhibition of the excessive glucose absorption in the small intestine
C.I. [98]
Increases in Ruminococcus intestinalis and Clostridium clusters I, II, and IV that are butyrate-producing. Decreases in fecal water genotoxicity C.I. [88]
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Biological and prebiotic effects Study typeReferences
Reduction of LDL cholesterol and total cholesterol C.I. [99]
Infants fed with formulas with PDX had softer stools (similar to breastfed infants) in comparison with those who receive unsupplemented
formulas
C.I. [100]
Increases in bifidobacteria and stools weight. Decreased in fecal ammonia, phenol, indoles and BCFA (isobutyrate, isovalerate, and valerate) C.I. [101]
Reduction of the orofecal transit time, and improvement of stool consistency in persons suffering from constipation C.I. [102]
Increases in Faecalibacterium prausnitzii numbers C.I. [103]
Reduction in fecal pH and improvement of stool consistency C.I. [104]
Supplementation with GOS–polydextrose and Lactobacillus rhamnosus GG in preterm infants reduces the risk of rhinovirus infections in infants C.I. [105]
The intake of yogurt with polydextrose, B. lactis HN019, and L. acidophilus NCFM® improved constipation C.I. [106]
Reduction of the production of biogenic amines and BCFA in rats. Improvement of the immune function A.S. [107]
Increases in defecation without diarrhea C.I. [108]
Increases in populations of bifidobacteria with a similar pattern with breastfed infants C.I. [109]
Increases in the number of bifidobacteria and selective stimulation of Bifidobacterium infantis compared with other carbohydrates tested in vitro [110]
Increases in bifidobacteria and lactobacilli and SCFA production in vitro [111]
Increases in the concentration of acetate and propionate and reduction of BCFA concentration. in vitro
(C.M.)
[112]
Increases in the production of fecal SCFA, especially acetate and propionate, and decreased fecal indole A.S. (dogs) [113]
Reduction of the expression of mucosal COX-2 (closely related to the colorectal cancer) A.S. (pigs) [114]
Increases in the content of ileal lactobacilli and in the levels of propionic and lactic acid. Reduction of cytokine expression A.S. (pigs) [89]
Reduction of chronic visceral hypersensitivity in rats exposed to early-life painful stimulus A.S. (rats) [115]
Improved calcium absorption in postmenopausal rats A.S. (rats) [116]
Ability to inhibit adherence of C. sakazakii to gastrointestinal epithelial cells in vitro [91]
Positive effect in canine osteoarthritis A.S. (dogs) [93]
Reduction of symptoms of allergen-induced dermatitis A.S.(mice) [94]
Stimulation of apoptosis in colon cancer cells in vitro
(C.M.)
[90]
A.S., animal study; C.I., clinical intervention; C.M., colonic model.
Table 1. Results obtained in studies carried out using polydextrose as substrate.
4. Algae-derived oligosaccharides
4.1. Structure, sources, and production
Seaweeds are a source of bioactive compounds like sulphated polysaccharides, proteins,
polyunsaturated fatty acids (PUFA), and polyphenols with potential beneficial health effects,
such as antibacterial [115], anti-inflammatory [116, 117], antioxidant [118–120], antitumoral
[121, 122], anticoagulant [123] antiadhesive [116], and apoptotic activities [124, 125] among
others. The major polysaccharides which can be found in seaweeds are alginates, laminarins,
fucans and cellulose in brown seaweeds, ulvan in green seaweeds, and agars and carrageen‐
ans in red seaweeds. Several extraction methods of bioactive sulphated polysaccharides from
seaweeds have been investigated in recent years, including: diluted acid extraction [126, 127],
hydrothermal processing [128], microwave-assisted extraction [129–131], ultrasound-assist‐
ed extraction [132], enzyme-assisted extraction [132, 133], or pressurized liquid extraction
[134].
4.2. Prebiotic properties
In the last decade, seaweed polysaccharides have been considered as dietary fibers and have
attracted much interest because of their potential use as prebiotics [135, 136]. In this sense,
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several studies have reported that seaweed polysaccharides resist the digestion in the upper
of gastrointestinal tract, support the growth of lactic acid bacteria, reduce of harmful bacte‐
ria as well as modulate the intestinal metabolism through their effects on pH and SCFA
concentration [137].
To date, several studies in vitro and in vivo were carried out to evaluate the potential prebiot‐
ic effects of seaweed polysaccharides. Table 2 summarizes the results obtained. No human
trials have been conducted yet using this type of substrates.
Product or seaweed Biological and prebiotic effects Study type References
Chondrus crispus and
Sarcodiotheca gaudichaudii
Increases in the numbers of Bif. longum and Streptococcus salivarius and reduction in the populations of C.
perfringens. Increases in SCFAs concentration and i-butyric acid.
A.S. (hens) [140]
Laminarin Increases in the levels of SCFAs In vitro
(HGM)
[137]
Laminarin Variations of mucus composition in jejunum, ileum, cecum, and colon A.S. (rats) [137]
Ascophyllum nodosum Reduction in populations of Escherichia coli In vitro
(PGM)
[141]
Carrageenans Increases in cecal moisture and in concentrations of acetic and propionic acid. Reduction in the levels of
triglycerides and total cholesterol
A.S. (rats) [142]
Alginate oligosaccharides Increases in numbers of fecal bifidobacteria and lactobacilli and reduced counts of bacteroides respect to the
FOS
A.S. (rats) [143]
Alginate oligosaccharides Stimulation of the growth of Bifidobacterium bifidum ATCC 29521 and Bifidobacterium longum SMU 27001 In vitro [143]
Saccharina latissima Increases in the concentrations of acetic and propionic acids A.S (rats) [144]
Laminarin and fucoidan Reduction in the populations of Enterobacteria and increases in the populations of Lactobacilli A.S. (pigs) [145]
Porphyran Increases in the content of propionic acid in the cecum. Decreases in the number of Clostridium coccoides. A.S. (mice) [146]
Carrageenan Increases in the populations of Bif. breve and reduction in the populations of Clostridium septicum and
Streptococcus neumoniae. Increases in the concentrations of SCFAs and immunoglobulin levels
A.S. (rats) [147]
Fucoidan and laminarin Increases in the counts of Lactobacillus and Bifidobacterium in the ileum A.S. (piglet)[148]
Low MW polysaccharides from
agar and alginate
Increases in the number of bifidobacteria. No effect on the populations of Lactobacilli, Bacteroides, Eubacterium
rectale/C. coccoides, and C. histolyticum
In vitro
(HGM)
[149]
Fucoidan Stimulation of apoptosis in HT-29 and HCT116 human colon cancer cells In vitro [150]
Himanthalia elongata Increases in the acetic, propionic, and butyric acids concentrations. Improvement of the lipid profile A.S. (rats) [151]
Fucoidan Inhibition of the adhesion of Helicobacter pylori to the gastric mucous In vitro [152]
C. crispus Enhancement of the host immunity and reduction of the infection by Pseudomonas aeruginosa In vitro [153]
A.S., animal study; C.I., clinical intervention; C.M., colonic model; HGM, human gut microbiota; PGM, pig gut microbiota.
Table 2. Results obtained in studies carried out using polysaccharides and oligosaccharides derived from algae as
substrates.
5. Bacterial exopolisaccharides
5.1. Structure, sources, and production
Bacteria can produce polysaccharides that usually play a protective role against environ‐
ment pressures. As these polymers are excreted into the extracellular surrounding, they are
known as EPS. They can occur in two forms (capsules or biofilm) [150, 151] and are classi‐
fied in two groups according to their composition:
• homo-EPSs made up of a single type of monosaccharide such as fructans, α-D-glucans, β-
D-glucans, dextran, curdlan, alternan, mutan, reuteran, or levan [152–154].
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• hetero-EPSs composed of different types of monosaccharides, mainly D-glucose, D-galac‐
tose, L-rhamnose, and their derivatives, such as xanthan, gellan, alginate, hyaluronan,
succinoglycan, kefiran, emulsan, galactoPol, or FucoPol [152–154]. The heteropolysacchar‐
ides are the most abundant bacterial EPSs.
The critical factors for maximum EPSs production are carbon and nitrogen sources, mineral
requirements, oxygen and aeration rate, temperature and pH [155], among others. Sugars are
the most commonly carbon sources used for the production of bacterial EPSs. However,
cheaper substrates, such as agro-food or industrial wastes and byproducts are suitable carbon
sources for EPSs production [153]. EPSs synthesis is generally favored by the presence of the
carbon source in excess, and the production of most bacterial EPSs occurs under aerobic
conditions [153].
On the other hand, the methods for EPSs extraction have a crucial influence as their
physicochemical properties could be affected by the isolation and purification techniques
[154]. It can be carried out by two methods: (i) by solvent precipitation when they are in slim
form and (ii) by alkaline extraction prior centrifugation and alcohol precipitation when they
are in form of capsule. The recovery is performed by solvent precipitation [155].
5.2. Biological properties
The EPSs have been proved to have functional roles in human or animal health including
immunomodulatory properties, antiviral, antioxidant, antimutagenecity, antihypertensive,
antiulcer, and antitumor activities, and have also been used as food additives for texture
improvement, as gelling agents or emulsifiers [152, 155, 156]. Moreover, EPSs may induce other
positive physiological responses including lower cholesterol levels, reduced formation of
pathogenic biofilms, modulation of adhesion to epithelial cells, and increased levels of
bifidobacteria, showing a prebiotic potential [157].
The use of bacterial EPSs as prebiotic substrates has been scarcely investigated [151]. Table 3
shows the results from some in vitro and in vivo assays that have explored the prebiotic potential
of this kind of substrates. Up to date, not human interventions with bacterial EPSs have been
carried out.
EPS type Producer strain Biological and prebiotic effects Study type References
Levan Lactobacillus sanfranciscensis
LTH1729, Lactobacillus
sanfranciscensis LTH2590
Bifidogenic effect; enhanced growth Eubacterium
biforme
In vitro (HGM) [162]
EPS (type not
identified)
Weissella cibaria A2, Weeissella
confusa A9, Lactobacillus plantarum
A3 and Pediococcus.pentosaceus 5S4
High resistance to gastric and intestinal digestions,
enhancement of growth of Bifibacterium bifidum and
some growth in case of B. longum, B. adolescentis,
and Lb. acidophilus
In vitro (pure
cultures)
[155]
EPS (type not
identified)
Weissella cibaria A2 Enhanced growth of Bifidobacterium and Lactobacillus
/Enteroccoccus groups, reduction of numbers of
Clostrida. Increase in SCFA concentrations (acetate,
propionate, butyrate)
In vitro (HGM) [155]
EPS (type not
identified)
B. animalis, B. pseudocatenultum, B.
longum
Increases in SCFA concentration and moderate
bifidogenic effect
In vitro (HGM) [163]
Fructan Lactobacillus sanfranciscensis TMW
1.392
Metabolized by B. breve, B. bifidum, B. adolescentis,
and B. infantis
In vitro (pure
cultures)
[164]
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EPS type Producer strain Biological and prebiotic effects Study type References
Dextran Leuconostoc mesenteroides NRRL
B-1426
Low digestibility by simulated human gastric juice,
high resistance to digestion by human a-amylases,
stimulated the growth of B. animalis, B. infantis, Lb.
acidophilus
In vitro (pure
cultures)
[165]
Reuteran Lb. reuteri TMW 1.656 Contribution to the prevention of enterotoxigenic E.
coli adhesion to the intestinal mucosa
In vivo (weanling
piglets)
[166]
EPS (type not
identified)
B. bifidum WBIN03 Significant inhibition of enterobacteria, enterococci,
and Bacteroides fragilis; significant enhancement of
the amount of Lactobacillus and total anaerobes
In vivo (mice) [167]
HGM, human gut microbiota.
Table 3. Results obtained in studies carried out using bacterial exopolysaccharides as substrates.
6. Sugar alcohols
6.1. Definition and production
Sugar alcohols are low digestible carbohydrates that are hydrogenated, which means that there
is an alcohol group (>CH–OH) in place of the carbonyl group (>C=O) in the aldose and ketose
moieties of mono-, di-, oligo- and polysaccharides [162]. They can be classified into three
groups: (i) hydrogenated monosaccharides (erythritol, xylitol, sorbitol, manitol); (ii) hydro‐
genated disaccharides (lactitol, isomalt, maltitol), and (iii) hydrogenated polysaccharides
(hydrogenated starch hydrolysates (HSHs), polyglycitols) [163].
Sugar alcohols occur naturally in certain fruits and vegetables, and some of them are even
generated by the human body. However, huge amounts of sugar alcohols are manufactured
for the food industry (Table 4) where they are used as replacers in foodstuffs performing
functions such as flavor enhancer, humectant, sweetener, anticaking agent, bulking agent,
glazing agent, stabilizer, thickener, emulsifier, and sequestrant [166].
Sugar alcoholNatural source Synthesis
Erythritol Vegetables, fruits (melons,
peaches, mushrooms, fermented
foods (wine, beer, sake, soy sauce)
Fermentation of glucose using yeasts or lactic acid bacteria
Xylitol Fruits, vegetables, berries, oats,
mushrooms
Metal catalyzed hydrogenation of D-xylose
Biotechnological production from corn cobs, waste of sugarcane, and other fibers using
yeasts
Sorbitol Apples, pears, apricots,
nectarines, prunes, dates, raisins
Catalytic hydrogenation of glucose or dextrose using Ni catalyst at high Tª.
Electrochemical reduction of dextrose at pH>7
Mannitol Fruits, vegetables, brown seaweeds,
wine
Fermentative process using lactic acid bacteria
Isomalt – Enzymatic transglucosidation of sucrose into maltulose and further hydrogenation
Lactitol – Catalytic hydrogenation of lactose using Raney nickel as catalyst
Maltitol – Catalytic hydrogenation of maltose or very high maltose glucose syrup
Polyglycitols/
HSHs
– Partial hydrolysis of starch (from corn, potato or wheat) resulting in dextrins that
undergoes subsequent hydrogenation
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Table 4. Natural sources and industrial synthesis of sugar alcohols [170, 171]
6.2. Biological properties
Sugar alcohols are characterized by their lower blood glucose response, and they can be
metabolized without insulin [166]. Although they are structurally similar to sugars, their
nutritional value is lower than them because they are only partially absorbed by the body, and
the absorbed portions are either poorly metabolized (e.g., erythritol) or excreted via the urinary
tract. The unabsorbed polyols are partially fermented in the colon, and they can modulate
beneficially the gut microbiota acting as prebiotics [109, 162]. Table 5 lists the results ob‐
tained in several studies that have been carried out with sugar alcohols.
Sugar alcoholBiological and prebiotic effects Study type References
Erythritol Not change on bacterial population dynamics but significant increase in acetate In vitro (human gut
microbiota)
[113]
Sorbitol Favors growth of autochthonous Lactobacillus species and increases colonic
production of butyrate
In vivo (in rat) [174]
Mannitol Modification of large intestine fermentation to produce more butyrate and propionate In vivo (in rat and pig
model)
[175]
Promotion of absorption and retention of Ca and Mg In vivo (in rat) [176]
Lowering effect on body fat accumulation and reduction of the level of serum
triglycerides
in vivo (in rat) [177]
Isomalt Significant increase in bifidobacteria and increase in butyrate, acetate and
propionate
In vitro (human gut
microbiota)
[113]
Lactitol Ability to reduce circulating levels of NH3 and toxic microbial substances, the clinical
utility of which is the treatment of hepatic encephalopathy
C.I. [178]
Reduction of levels of plasma endotoxin in chronic viral hepatitis through improving
intestinal microbiota
C.I. [179]
Significant increases in counts of Bifidobacterium and both propionic and butyric acids
and significant reduction of fecal pH with a consumption of 10 g/d
C.I. [180]
Fermentation by pure cultures of Bifidobacterium lactis Bi-07, Lactobacillus acidophilus
NCFM, Lactobacillis paracasei Lpc-37, Lactobacillus rhamnosus HN001
In vitro (pure cultures) [181]
Increase fecal numbers of L. acidophilus NCFM. No significant changes in SCFA and
fecal concentrations of spermicine and PGE2
C.I. [182]
Significant increase in bifidobacteria and increases in butyrate, acetate and
propionate
In vitro (human gut
microbiota)
[113]
Maltitol Significant increase in bifidobacteria, minor increase in Lactobacillus/enterococci, and
increases in major SCFA (acetate, propionate, and butyrate)
In vitro (human gut
microbiota)
[113]
Significant increases in bifidobacteria, lactobacilli, clostridium histolyticum/perfringens
populations, bacteroides, Fusobacterium prausnitzii, E. rectal, R. flavefaciens, Atopobium, R.
bromii, and in major SCFA (acetate, propionate, and butyrate)
C.I. [183]
C.I., clinical intervention.
Table 5. Biological and prebiotic effects of sugar alcohols.
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